Argenx Expands Immunology Platform with Unnatural Products & Wins Strong Phase III ALKIVIA Results
Argenx expands its immunology platform with the Unnatural Products acquisition and unveils strong Phase III results for ALKIVIA, promising new autoimmune therapy.
3 minutes to read

